Turning an SPA rejection into BLA Submission Success
Veristat supported a Sponsor from SPA rejection to BLA submission, bringing strategic expertise to a small client team tackling their first clinical...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
1 min read
JoAnn Vormschlag : Published Updated
Join Veristat and industry leaders in regulatory writing and submissions management at the upcoming 5th Annual Regulatory Writing for Product Approvals Conference to share and discuss the challenges of writing regulatory submissions in a continually changing regulatory environment.
On Thursday, April 28 at 10:40 AM, we invite you to join Paula Wun and an esteemed panel of industry experts will discuss the following:
EDITING CONSIDERATIONS
FOR SUBMISSION DOCUMENTS
Paula Wun, Senior Director, Medical Writing
Veristat
We hope to see you at this exciting panel discussion.
Veristat can offer you strategic guidance in planning for your regulatory submission, we provide representation at the agency meetings, and we provide the statistical as well as medical writing support to prepare the submission documents. We have over 20 years of experience helping clients prepare INDs, CTAs, NDAs, BLAs, and MAAs.
Schedule a time to speak with Paula or any of Veristat’s experts at the show about the challenges you are trying to overcome with your current or upcoming submission project.
Veristat supported a Sponsor from SPA rejection to BLA submission, bringing strategic expertise to a small client team tackling their first clinical...
Veristat will streamline the medical writing process for simultaneous regulatory submissions. Learn how Veristat can help your clinical development...
Discover how Veristat's expertise in IND submissions and strategic planning paved the way for a small-sized biotech company to advance into a Phase I...